https://www.avient.com/sites/default/files/2024-08/AVNT Second Quarter Earnings Press Release.pdf
2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the
establishment, reversal or changes to valuation allowances.
10
Attachment 4
Avient Corporation
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
June 30, 2024
December 31,
2023
ASSETS
Current assets:
Cash and cash equivalents $ 489.4 $ 545.8
Accounts receivable, net 486.6 399.9
Inventories, net 365.9 347.0
Other current assets 117.2 114.9
Total current assets 1,459.1 1,407.6
Property, net 1,019.9 1,028.9
Goodwill 1,685.1 1,719.3
Intangible assets, net 1,515.7 1,590.8
Other non-current assets 228.0 221.9
Total assets $ 5,907.8 $ 5,968.5
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term and current portion of long-term debt $ 657.7 $ 9.5
Accounts payable 435.2 432.3
Accrued expenses and other current liabilities 405.3 331.8
Total current liabilities 1,498.2 773.6
Non-current liabilities:
Long-term debt 1,420.8 2,070.5
Pension and other post-retirement benefits 63.3 67.2
Deferred income taxes 276.3 281.6
Other non-current liabilities 315.0 437.6
Total non-current liabilities 2,075.4 2,856.9
SHAREHOLDERS' EQUITY
Avient shareholders’ equity 2,317.5 2,319.2
Noncontrolling interest 16.7 18.8
Total equity 2,334.2 2,338.0
Total liabilities and equity $ 5,907.8 $ 5,968.5
11
Attachment 5
Avient Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Six Months Ended
June 30,
2024 2023
Operating Activities
Net income $ 83.5 $ 42.7
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization 88.4 96.2
Accelerated depreciation 0.8 1.9
Share-based compensation expense 9.0 6.5
Changes in assets and liabilities:
Increase in accounts receivable (97.0) (66.6)
(Increase) decrease in inventories (27.3) 14.0
Increase (decrease) in accounts payable 11.9 (26.2)
Taxes paid on gain on sale of business — (103.0)
Accrued expenses and other assets and liabilities, net (6.2) 9.8
Net cash provided (used) by operating activities 63.1 (24.7)
Investing activities
Capital expenditures (55.8) (45.9)
Net proceeds from divestiture — 7.3
Proceeds from plant closures 3.4 —
Other investing activities (2.1) —
Net cash used by investing activities (54.5) (38.6)
Financing activities
Cash dividends paid (47.0) (45.0)
Repayment of long-term debt (4.5) (1.0)
Other financing activities (3.3) (2.3)
Net cash used by financing activities (54.8) (48.3)
Effect of exchange rate changes on cash (10.2) (0.8)
Decrease in cash and cash equivalents (56.4) (112.4)
Cash and cash equivalents at beginning of year 545.8 641.1
Cash and cash equivalents at end of period $ 489.4 $ 528.7
12
Attachment 6
Avient Corporation
Business Segment Operations (Unaudited)
(In millions)
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not
include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to
segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not
included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.
https://www.avient.com/industries/healthcare/medical-devices-equipment/surgical-medical-instruments
Developing surgical tools and accessories is a delicate balance of functionality, safety, biocompatibility, and durability.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale in Turkey.pdf
Buyer
acknowledges that information in Seller’s
marketing materials, technical data sheets and
other descriptive publications distributed or
published on its websites may vary from time to
time without notice.
Buyer acknowledges that Seller has
furnished to Buyer Safety Data Sheets, which
include warnings together with safety and health
information concerning the Product and/or the
containers for such Product.
In the event of invalidity of a
provision of these Terms, the parties shall deem
that provision stricken in its entirety and the
balance of these Terms shall remain in full force
and effect.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the Kingdom of Saudi Arabia.pdf
Buyer
acknowledges that information in Seller’s marketing materials, technical
data sheets and other descriptive publications distributed or published on
its websites may vary from time to time without notice.
Buyer acknowledges that Seller has furnished to
Buyer Safety Data Sheets, which include warnings together with safety and
health information concerning the Product and/or the containers for such
Product.
In the event of invalidity of a provision of these Terms,
the parties shall deem that provision stricken in its entirety and the balance
of these Terms shall remain in full force and effect.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Brazil %28English and Spanish Translation%29.pdf
Buyer acknowledges that information
in Seller’s marketing materials, technical data sheets
and other descriptive publications distributed or
published on its websites may vary from time to time
without notice.
Buyer
acknowledges that Seller has furnished to Buyer Safety
Data Sheets, which include warnings together with
safety and health information concerning the Product
and/or the containers for such Product.
In the event of invalidity of a provision of
these Terms, the parties shall deem that provision
stricken in its entirety and the balance of these Terms
shall remain in full force and effect.
26.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Chile %28English and Spanish Translation%29.pdf
Buyer
acknowledges that information in Seller’s marketing
materials, technical data sheets and other descriptive
publications distributed or published on its websites
may vary from time-to-time without notice.
Buyer acknowledges that Seller has
furnished to Buyer Safety Data Sheets, which
include warnings together with safety and health
information concerning the Product and/or the
containers for such Product.
In the event of invalidity of a provision
of these Terms, the parties shall deem that provision
stricken in its entirety and the balance of these
Terms shall remain in full force and effect.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Guatemala %28English and Spanish Translation%29.pdf
Buyer
acknowledges that information in Seller’s
marketing materials, technical data sheets and
other descriptive publications distributed or
published on its websites may vary from time to
time without notice.
Buyer acknowledges
that Seller has furnished to Buyer Safety Data
Sheets, which include warnings together with
safety and health information concerning the
Product and/or the containers for such Product.
In the event of invalidity of a
provision of these Terms, the parties shall deem
that provision stricken in its entirety and the
balance of these Terms shall remain in full force
and effect.
https://www.avient.com/sites/default/files/2024-09/Terms and Conditions of Sale for Italy.pdf
Buyer acknowledges that information in Seller’s marketing
materials, technical data sheets and other descriptive
publications distributed or published on its websites may
vary from time to time without notice.
Buyer acknowledges that Seller has
furnished to Buyer Safety Data Sheets, which include
warnings together with safety and health information
concerning the Product and/or the containers for such
Product.
Scindibilità
In the event of invalidity of a provision of these Terms, the
parties shall deem that provision stricken in its entirety and
the balance of these Terms shall remain in full force and
effect.
https://www.avient.com/sites/default/files/resources/PDI_Case_Study_-_Medical_Device_0.pdf
This information
sheet shall NOT operate as permission, recommendation, or inducement to practice any patented invention without permission of the patent owner.
https://www.avient.com/sites/default/files/2021-06/plastisol-storage-handling-technical-bulletin.pdf
As a result of these plastisol aging characteristics
and the potential differences in testing
methodology, it is strongly recommended that
incoming quality control (QC) specifications not
be established based on plastisol Technical Data
Sheets (TDS), or Certificates of Analysis (COA).